<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A hallmark of various human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> is the expression of immunoinhibitory factors within the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment </plain></SENT>
<SENT sid="1" pm="."><plain>There is indirect evidence based on in vitro experiments that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating T cells in human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> are suppressed by such factors </plain></SENT>
<SENT sid="2" pm="."><plain>Still, direct evidence of the influence of individual inhibitory factors on immune cells in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in vivo is lacking </plain></SENT>
<SENT sid="3" pm="."><plain>To address this question, we used Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) as a model because histopathological characteristics of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> are thought to be due mostly to the effects of a wide variety of cytokines, including TGFbeta or membrane-bound receptors such as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 that are suspected to contribute to immune evasion of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Using a genome-wide transcriptional approach, we established specific <z:chebi fb="40" ids="33697">RNA</z:chebi> fingerprints of TGFbeta and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 signaling in human T cells in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>Applying these specific fingerprints, we directly demonstrate that CD4+ T cells in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>--but not in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL)--are under the inhibitory influence of both TGFbeta and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 in vivo </plain></SENT>
<SENT sid="6" pm="."><plain>This approach can be easily generalized to provide direct evidence of the impact of any given soluble or cell-bound factor on any cell type within diseased tissue </plain></SENT>
</text></document>